Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
MSOX
)
0.9105
+0.1370 (+17.71%)
Official Closing Price
Updated: 8:00 PM EST, Nov 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MSOX
AdvisorShares MSOS Climbs 8% As Cannabis Rescheduling Sparks Investor Interest
October 23, 2024
AdvisorShares MSOS ETF surges 8% as U.S. cannabis reform nears. Explore key investment signals and market opportunities.
Via
Benzinga
Topics
Cannabis
ETFs
Exposures
Cannabis
New SEC Filings Reveal Major Risks In Cannabis ETFs Following Recent Volatility — But There's Still Room for Optimism
August 22, 2024
Cannabis ETFs MSOS and MSOX facing regulatory uncertainty and market downturn, with potential for rebound if federal law is amended.
Via
Benzinga
Topics
Cannabis
ETFs
Regulatory Compliance
Exposures
Cannabis
Legal
Regulatory
Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana
April 30, 2024
The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decision to align its stance with a recommendation from the Department of Health and...
Via
Benzinga
Topics
Cannabis
ETFs
Exposures
Cannabis
There Is No Comparison Between These 9 Cannabis ETFs
April 02, 2024
This article discusses the cannabis industry and the 9 cannabis ETFs that are available.
Via
Talk Markets
Topics
Cannabis
ETFs
Exposures
Cannabis
Dazed By The Cannabis ETF Whirlwind? Here Is A Short Guide To Survival
February 09, 2024
Explore the volatile cannabis ETFs market, trends, disparities, and the future landscape. Expert insights reveal investment strategies.
Via
Benzinga
Topics
Cannabis
ETFs
Exposures
Cannabis
Cannabis Stocks And ETFs Trading Higher As Government Recommendations Ignite Hope For Industry
January 16, 2024
Cannabis stocks and ETFs opened higher on Tuesday following the release of documents related to the Department of Health and Human Service's (HHS) review of cannabis. Investors are optimistic about...
Via
Benzinga
Topics
Cannabis
ETFs
Exposures
Cannabis
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 16, 2024
We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning!
Via
InvestorPlace
5 Top-Performing Leveraged ETFs Of Blockbuster November
December 01, 2023
Here is a bunch of the best-performing leveraged equity ETFs from different corners of the market that are leaders in their segments.
Via
Talk Markets
Topics
ETFs
U.S. Cannabis: Growth At A Reasonable Price?
November 15, 2023
By Todd Harrison via Cannabis Confidential (Nov 14)
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
5 Leveraged/Inverse ETFs That Gained More Than 40% In Q3
October 02, 2023
The third quarter proved to be highly volatile and uncertain for the U.S. stock market. This has resulted in huge demand for leveraged or inverse-leveraged ETFs as these fetch outsized returns on quick...
Via
Talk Markets
Topics
ETFs
Federal Agency Gives Green Light: How Relaxed Marijuana Laws Could Boost U.S. Stocks
September 05, 2023
The weekend was abuzz with anticipation after the HHS recommended to reschedule cannabis last Wednesday.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
5 Best Leveraged ETFs Of November
December 01, 2022
Here are the best-performing leveraged equity ETFs from different corners of the market that gained more than 25% in November.
Via
Talk Markets
AdvisorShares Expands Cannabis ETF Offerings, Launches MSOS 2X Daily ETF MSOX
August 24, 2022
AdvisorShares revealed that the AdvisorShares MSOS 2x Daily ETF (ARCA:MSOX) will begin trading on August 24th.
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.